Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana

Pathogens
Bonolo B PhiniusSimani Gaseitsiwe

Abstract

People with concomitant human immunodeficiency virus (HIV) and tuberculosis (TB) have an increased risk of hepatotoxic reactions due to antiretroviral therapy (ART) and anti-TB therapy (ATT). Concomitant hepatitis B virus (HBV) in these patients may lead to poorer health outcomes. To assess liver enzyme levels and immune response in adults with HIV, HBV, and TB, data from 300 antiretroviral-naïve people living with HIV (PLWHIV) were analyzed. The prevalence of HIV/HBV (cHIV/HBV) and HIV/TB (cHIV/TB) was 28% (95% CI: 23.0-33.4) and 10% (95% CI: 6.8-14.0), respectively. HIV/HBV/TB (cHIV/HBV/TB) prevalence was 5.3% (95% CI: 3.1-8.5). There was a statistically significant difference between the groups of participants in HIV viral load (p = 0.004), hemoglobin levels (p = 0.025), and body mass index (p = 0.011). A larger proportion of cHIV/HBV/TB participants (37.5%) had an aspartate aminotransferase to platelet ratio index (APRI) score ≥0.5 (p = 0.013), a lower cutoff for significant liver fibrosis. Immunological non-responders (CD4+ T-cell count <20% gain and HIV viral load <400 copies/mL at 6 months) were observed in all groups except those with cHIV/TB. Our findings support the need to screen for infections that could cause exces...Continue Reading

References

Jul 4, 2003·Postgraduate Medical Journal·J K Limdi, G M Hyde
Feb 24, 2006·Epidemiology and Infection·R E Watkins, A J Plant
Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C William WesterRichard G Marlink
Jan 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara H McGovernTamsin A Knox
Aug 30, 2008·Nature Reviews. Immunology·Eleanor N Fish
May 28, 2010·AIDS·Colleen F HanrahanNeil A Martinson
Jul 9, 2010·The Lancet Infectious Diseases·Kayvon Modjarrad, Sten H Vermund
Aug 5, 2011·The American Journal of Tropical Medicine and Hygiene·Premal PatelGabriel Anabwani
Apr 5, 2012·Clinical & Developmental Immunology·Julie C GaardboSusanne D Nielsen
Feb 1, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael SchomakerUNKNOWN IeDEA Southern Africa
Jun 27, 2014·The Journal of Infectious Diseases·Shepherd Nhamoyebonde, Alasdair Leslie
Sep 15, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Pingzheng MoXi-en Gui
Jan 13, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Michael J VinikoorBenjamin H Chi
May 1, 2015·AIDS Research and Human Retroviruses·Jean Claude DusingizeKathryn Anastos
Jan 12, 2016·Journal of Global Infectious Diseases·Cecilia T CostiniukMahomed Yunus S Moosa
Jul 12, 2017·Journal of the International AIDS Society·Lukas FennerUNKNOWN International Epidemiology Database to Evaluate AIDS in Southern Africa (IeDEA-SA)
Oct 4, 2017·Journal of Clinical and Diagnostic Research : JCDR·Vijeta BajpaiS M Shashtry
Oct 11, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Claudia HawkinsRobert Murphy
Nov 17, 2017·BMC Infectious Diseases·Patrick A CoffieUNKNOWN IeDEA collaboration
May 19, 2018·Genes·Tshepiso MbangiwaSimani Gaseitsiwe
Nov 2, 2018·Virus Genes·Wonderful T ChogaSimani Gaseitsiwe

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
enzyme-linked immunosorbent assays
ELISA

Software Mentioned

FibroTest
FibroScan
STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Mamta K JainWilliam M Lee
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
John IdokoChloe L Thio
© 2021 Meta ULC. All rights reserved